ReviewJournal of racial and ethnic health disparities2026
Challenges in Skin Cancer Screening and Access to Treatment Among Multiple U.S. Racial and Ethnic Population Groups: A Systematic review.
Review in Journal of racial and ethnic health disparities, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundSkin cancer remains the most common malignancy in the United States, yet disparities in screening, diagnosis, treatment, and outcomes persist among racial, ethnic, and underserved populations. Minority groups are more likely to present with advanced-stage disease and experience worse survival outcomes compared with non-Hispanic White populations. This systematic review synthesized contemporary U.S.-based evidence examining barriers to skin cancer prevention, detection, and treatment among underserved populations.
methodsGuided by the Arksey and O'Malley framework and reported in accordance with PRISMA guidelines, we searched PubMed, Embase, and Cochrane databases for studies published between 2009 and 2024. Inclusion criteria encompassed U.S.-based studies evaluating disparities in skin cancer screening, diagnosis, treatment, or outcomes among racial and ethnic minority populations. Forty-seven studies met inclusion criteria. Data were extracted and synthesized using the Social-Ecological Model (SEM) and mapped to Healthy People 2030 domains.
resultsConsistent disparities were identified across the care continuum. Minority and socioeconomically underserved populations were more likely to experience delayed diagnosis, advanced-stage presentation, treatment delays, and poorer survival outcomes. Insurance status, socioeconomic position, education, geographic access, and provider-level factors, including limited training in skin of color, were prominent contributors. A total of 516 barriers were identified across SEM levels, with individual, organizational, and societal barriers most frequently reported. Misdiagnosis and atypical clinical presentations, including acral lentiginous melanoma, further compounded barriers in accessing care.
conclusionsSkin cancer rates in the U.S. are multifactorial and structurally embedded. Multilevel interventions addressing insurance continuity, dermatologic workforce distribution, culturally tailored education, and enhanced provider training in diverse skin presentations are necessary to advance optimal skin cancer outcomes. REGISTRATION: This systematic review was registered on PROSPERO (ID # 1023303).
Indexed as
Identifiers
42642710What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.